Trial
NCT00343655
Evaluation of Atorvastatin Treatment on Carotid Plaque.
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Collaborators
—
Condition
Cardiovascular Diseases
Intervention
Atorvastatin
Why stopped
The study was terminated on June 22, 2007 for inability to enroll patients within an appropriate timeframe. There were no efficacy/safety concerns.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-02-18